CVE-2024-27264: ibm i Improper Privilege Management
CVSS: 7.8v3.1HighAnalyzed
Published 22-05-2024Last modified 02-08-2024
Vulnerability summary
CVE-2024-27264 is a high (CVSS 7.8) Improper Privilege Management vulnerability in ibm i. EPSS estimates a 0.14% chance of exploitation in the next 30 days, higher than 2.8% of scored vulnerabilities.
CVSS score
7.8/10
010
High · v3.1 (NVD)EPSS score
0.14%
0%100%
Low · 0.00 pp in 30 daysKEVNot listedIn no KEV catalog
RansomwareNone recordedNo known use recorded
Public exploits0No public exploits recorded
Timeline
- 22-05-2024PublishedVulnerability first disclosed.
- 02-08-2024Last modifiedVulnerability information updated.
Description
IBM Performance Tools for i 7.2, 7.3, 7.4, and 7.5 could allow a local user to gain elevated privileges due to an unqualified library call. A malicious actor could cause user-controlled code to run with administrator privilege. IBM X-Force ID: 284563.
CVSS metrics
2 scores · 2 sources · 1 versionHigh 7.8Preferred score · NVD (NIST)
CVSS:3.1/AV:L/AC:L/PR:L/UI:N/S:U/C:H/I:H/A:HSources2 sources · 7.4–7.8
- CVE.orgCNA7.4HighCVSS:3.1/AV:L/AC:H/PR:N/UI:N/S:U/C:H/I:H/A:HDiffers
EPSS trend
Probability
0.14%
Chance of exploitation in the next 30 days
Percentile
3%
Versus all other CVEs
30-day change
0.00 pp
From 0.14% on 21-09-2026
21-09-202621-10-2026
EPSS score0.14%
Known exploited
Compare KEV catalogsNot in any of the 3 tracked catalogs.
Public exploits
0 foundNo public exploits indexed.
Weaknesses
CWE · root cause- CWE-269Improper Privilege ManagementThe product does not properly assign, modify, track, or check privileges for an actor, creating an unintended sphere of control for that actor.
- CWE-276Incorrect Default PermissionsDuring installation, installed file permissions are set to allow anyone to modify those files.
- CWE-284Improper Access ControlThe product does not restrict or incorrectly restricts access to a resource from an unauthorized actor.
Affected systems
Ibm1 product
- i7.2, 7.3, 7.4, 7.5 | 7.2 | 7.3 | 7.4 | 7.5
1 vendor · 1 product
References
2 links- www.ibm.com/support/pages/node/7154595Vendor Advisory